Lyme Science Blog
Dr. Daniel Cameron, MD, MPH, is a nationally recognized leader for his expertise in the diagnosis and treatment of Lyme disease and other tick-borne illnesses. His weekly Lyme Disease Science blog features articles covering the latest research, insights and case reviews.
Lyme Science Blog
Patients can die when Lyme carditis is not treated
Lyme disease can lead to acute and chronic illness. But deaths from Lyme disease can occur. “Death can occur when
Lyme Science Blog
Doxycycline for children with Lyme disease. Pros and cons.
Tetracyclines, including doxycycline, are typically not recommended for treating young children with lyme disease because the antibiotic may cause permanent
Lyme Science Blog
Bannwarth syndrome and weight loss – an atypical case
Bannwarth syndrome is typically seen in Europe. However, in 2017 doctors from Mayo Clinic described 5 patients with the disease
Lyme Science Blog
Treatment guidelines for Lyme disease strike out. An editorial.
There is growing evidence supporting the existence and severity of chronic manifestations of Lyme disease despite recent treatment guidelines for
Lyme Science Blog
Study identifies189 children with Lyme carditis
In their article addressing the heart and Lyme disease “Increasing Burden of Lyme Carditis in United States Children’s Hospitals,” Beach
Lyme Science Blog
Brain MRI in Lyme disease
The authors review the role of medical imaging for various infectious diseases including the Zika virus, measles, influenza, Chagas disease,
Lyme Science Blog
C6 peptide test may indicate Borrelia miyamotoi infection
Koetsveld and colleagues examined C6 reactivity in sera from both mice infected with Borrelia miyamotoi and from 46 patients with
Lyme Science Blog
Treatment of Lyme arthritis with disease-modifying antirheumatic drugs (DMARD)
Antirheumatic drugs (DMARDs) are intended to slow down disease progression. Synthetic DMARDs include methotrexate and sulfasalazine. Biological DMARDs include the
Lyme Science Blog
Could advanced imaging reveal cognitive impairment in the brain of a Lyme disease patients?
Multiple studies indicate that neurotransmitter levels can be “related to measures of behavioral outcomes, such as memory, reaction timing,” writes